1 |
Fisher LAB, Schöck F. The unexpected versatility of ALP/Enigma family proteins. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.963608] [Reference Citation Analysis]
|
2 |
Cox OT, O’sullivan N, Tresse E, Ward S, Buckley N, O’connor R. PDLIM2 is highly expressed in Breast Cancer tumour-associated macrophages and is required for M2 macrophage polarization. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1028959] [Reference Citation Analysis]
|
3 |
Yang S, Zhou C, Zhang L, Xiong Y, Zheng Y, Bian L, Liu X. Proteomic landscape of primary and metastatic brain tumors for heterogeneity discovery.. [DOI: 10.21203/rs.3.rs-2258430/v1] [Reference Citation Analysis]
|
4 |
Piao S, Zheng L, Zheng H, Zhou M, Feng Q, Zhou S, Ke M, Yang H, Wang X, Wang F. High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration. Journal of Immunology Research 2022;2022:1-28. [DOI: 10.1155/2022/2922832] [Reference Citation Analysis]
|
5 |
Zeng Y, Lin D, Gao M, Du G, Cai Y. Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types. Sci Rep 2022;12:1933. [PMID: 35121770 DOI: 10.1038/s41598-022-05987-1] [Reference Citation Analysis]
|